Samsung Bioepis and Teva expanded their partnership to develop and commercialize up to six biosimilar candidates. See which ...

Astrocyte Pharmaceuticals secures $9.5M Series B funding to advance AST-004 into Phase II trials for concussion and TBI ...

CMS finalized the mandatory GLOBE model, linking Medicare Part B rebates to international drug prices starting in 2027. See ...

Foghorn Therapeutics is cutting about 40% of its workforce after ending FHD-909 and other SMARCA2 programs with Lilly. Read ...

Atara Biotherapeutics resubmits tabelecleucel BLA to FDA for EBV+ post-transplant lymphoproliferative disease. Latest updates ...

Progentos begins Phase I/II human trial of oral PRO-1562 for multiple sclerosis remyelination. First-in-human study ...

Regeneron and Sanofi expand antibody alliance with $1B upfront and $7B in milestones for IL-4/IL-13 pathway treatments. Learn ...

AbbVie's amylin analog ABBV-295 achieves every-other-week dosing with significant weight loss in Phase I obesity trial. Full ...

Varda Space Industries secures $251M Series D funding to scale space-based pharmaceutical manufacturing. Learn how orbital ...

NRx Pharmaceuticals wins $11.2M DARPA funding to test NRX-101 combined with robotic TMS for treatment-resistant depression.

Eli Lilly's Ebglyss meets primary endpoints in Phase IIIb ADtouch trial for moderate-to-severe hand and foot atopic dermatitis. Label expansion expected.

CAS and Novartis collaborate on AI-ready reaction informatics for drug discovery. Access 160M+ curated reactions. Learn how ...